BTX News and Press, Brooklyn ImmunoTherapeutics Inc. From 07/19/21

Brooklyn ImmunoTherapeutics ([[BTX]] -4.5%) has completed its acquisition of Novellus Therapeutics.The transaction advances Brooklyn’s evolution into a platform company with a pipeline of next-generation engineered cellular, gene editing and cytokine programs. Key transaction highlight...

Acquisition Advances Transformation Into Platform Company Focused on Cell, Gene Editing and Cytokine Therapy Company to hold Conference Call Today, July 19, 2021, at 4:15PM ET to Discuss the Transaction and Future Plans NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- ...

NEW YORK, July 13, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorder...

Gainers: Tempest Therapeutics (TPST) +98%, Xtant Medical (XTNT) +31%, Celldex Therapeutics CLDX +29%, SCWorx (WORX) +20%, ReShape Lifesciences (RSLS) +12%.Losers: Sigilon Therapeutics (SGTX) -9%, TransMedics (TMDX) -8%, Prothena PRTA...

NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) (“Brooklyn” or “the Company”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pharmaceutical companies can be a great investment. Especially for investors in search of long-term growth candidates for their portfolio. A successful new drug or treatment is covered by patents for 20 years in the U.S. m...

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13 th - 15 th , 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meeti...

Companies engaged in developing therapies for Alzheimer's disease were among the best performing biotech stocks in the first half of the year.Cassava Sciences ([[SAVA]] -1.7%) was the best performing biotech stock in the half, with a return in the period of 1166%.A phase 3 trial of its Alzhei...

Were These On Your List Of Penny Stocks This Month? Looking for penny stocks to buy right now? If you answered yes, you’re not alone. While this month has been a mixed one for broader markets, low-priced names have grabbed attention. Sure, AMC Entertainment ( NYSE: AMC ) and ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It may not last forever. But, the Reddit stocks phenomenon is here to stay for now. It may go against the philosophy of  investing legends like Warren Buffett . But, as retail investors continue to essentially gambl...